Abstract
There is currently very strong cross-sectional and prospective epidemiological data showing that low bone mass is a major risk factor for osteoporotic fractures. The prevention of bone loss caused by estrogen deficiency, calcium and vitamin D deficiency or other causes could therefore significantly reduce the incidence of osteoporotic fractures. Increased understanding of the pathophysiology of the bone loss that commonly occurs after the fourth decade in life, and the ability to control it by hormone replacement therapy or pharmacological means, offer good hope for making osteoporosis, as we know it today, a disease of the past.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Peck WA, et al. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993;94:646–50.
Johnston CC Jr, Miller JZ, Slemenda CW, et al. Calcium supplementation and increases in bone mineral density in children. N Engl J Med 1992;327:82–7.
Felson DT, Zhang Y, Hannan MT, et al. The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med 1993;329:1141–93.
Williams GT, Smith CA. Molecular regulation of apoptosis: genetic controls on cell death. Cell 1993;74:777–9.
Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992;327:1637–42.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rodan, G.A. Good hope for making osteoporosis a disease of the past. Osteoporosis Int 4 (Suppl 1), S5–S6 (1994). https://doi.org/10.1007/BF01623428
Issue Date:
DOI: https://doi.org/10.1007/BF01623428